ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 114 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $61,000 | +24.5% | 31,900 | +155.2% | 0.00% | – |
Q4 2021 | $49,000 | -92.2% | 12,500 | -91.4% | 0.00% | -100.0% |
Q3 2021 | $626,000 | +1390.5% | 145,800 | +1046.3% | 0.01% | +500.0% |
Q1 2021 | $42,000 | -94.6% | 12,719 | -89.8% | 0.00% | -98.6% |
Q3 2017 | $775,000 | – | 125,000 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
Kepos Capital LP | 200,000 | $778,000 | 0.06% |
XTX Topco Ltd | 29,026 | $113,000 | 0.06% |